A US drug company says it has shaped the first therapy that could slow Alzheimer's disease, and it is now ready to take to market. Presently, there are no drugs that can do this - common ones only help with symptoms. Biogen says it will soon seek supervisory approval in the US for the "groundbreaking" drug, called aducanumab.
It strategizes to file the paperwork in early 2020 and has its sights on Europe too. Approval p....
Tags : US drug company, Biogen, Alzheimer, Dementia,
comments (0)